The outcomes of pregnancy after metabolic and bariatric surgery: a literature review Authors: Parisa Keshtkaran, Atefe Hashemi, Mahsa Razeghi, Mina Moosaie, Shaghayegh Moradi Alamdarloo Published: 2025 ABSTRACT AbstractPurposeThe main purpose of this review is to examine the outcomes of pregnancy following different metabolic and bariatric surgical procedures.MethodsA comprehensive literature search was conducted in PubMed for studies published between 2014 and 2024, focusing on pregnancy outcomes after bariatric surgery. The review analyzed outcomes across different surgical procedures: Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), adjustable gastric banding (AGB), and biliopancreatic diversion with duodenal switch (BPD-DS).ResultsMetabolic and bariatric surgery demonstrates significant benefits in reducing obesity-related pregnancy complications, including decreased rates of gestational diabetes and hypertensive disorders. However, procedure-specific risks were identified: RYGB showed increased risks of internal herniation and nutritional deficiencies; SG demonstrated more stable glycemic profiles with lower rates of complications; AGB required ongoing adjustment during pregnancy; and BPD-DS presented the highest risk of nutritional deficiencies. Small-for-gestational-age births were more common after malabsorptive procedures compared to restrictive ones. The traditional recommendation of waiting 12–24 months before conception appears oversimplified, with evidence suggesting procedure-specific timing considerations may be more appropriate.ConclusionsWhile all bariatric procedures improve pregnancy outcomes compared to untreated obesity, the choice of procedure for women of reproductive age should carefully consider the balance between metabolic benefits and potential risks to maternal and fetal health. Individualized, procedure-specific approaches to post-surgical care and pregnancy timing are recommended.Keywords: Metabolic and bariatric surgery, Pregnancy outcomes, Maternal obesity, Fetal outcomes, Gestational diabetes Background As defined by the World Health Organization (WHO), in adults, overweight is a Body Mass Index (BMI) greater than or equal to 25 and obesity is a BMI greater than or equal to 30 [1]. Obesity, with a prevalence of 13% among adults until 2018 worldwide and contracting one third of the United States’ population, has emerged to be a great global health problem [2]. In addition to that, by estimates of WHO, in 2022, 43% of adults worldwide are considered overweight with a BMI more than 25 kg/m2, and 16% are living with obesity, showing an increasing trend in this issue [1]. Obesity before pregnancy and excessive gestational weight gain are associated with a higher risk of miscarriage, gestational diabetes (GDM), pregnancy-induced hypertension (PIH), preeclampsia, venous thromboembolism, induced labor, prolonged labor, cesarean section, anesthetic complications, and wound infections [3]. Mother’s obesity poses some risks to infants too, like large-for-gestational-age offspring, neurological and cardiovascular malformations, cleft palate and lips [4], and also obesity and metabolic syndrome later in childhood [3]. Currently there is no universal evidence-based guideline for management of overweight and obesity in pregnancy, but several institutional guidelines and recommendations have been made, addressing this problem. Weight loss prior to conception [5], regular exercise [6], behavioral intervention programs, and metabolic and bariatric surgery (MBS) have all been proposed as proper methods for managing overweight and obesity in pregnancy [7]. MBS includes a group of surgical procedures, developed to improve obesity-related disorders [8]. It offers the most effective and durable outcome for many patients, to lose a significant amount of weight, and see improvement in obesity-related comorbidities [9]. MBS consists of restrictive procedures, like adjustable gastric banding, and malabsorptive procedures that may also restrict the stomach volume, like Roux-en-Y bypass and biliopancreatic diversion [3]. MBS has a long history dating back to the tenth century, with early techniques focusing on restrictive approaches, like jaw wiring and gastric banding, until the 1960s when gastric bypass procedures were introduced. The current trends in MBS heavily favor laparoscopic Sleeve Gastrectomy (SG) and Roux-en-Y Gastric Bypass (RYGB) as the most commonly performed procedures globally. Recent studies indicate that laparoscopic SG accounts for over 50% of all bariatric interventions, becoming the primary choice for many healthcare providers due to its effectiveness in weight loss and favorable safety profile [10, 11]. In parallel, RYGB continues to be a popular option, representing a significant portion of bariatric surgeries performed and generally providing extensive weight loss and metabolic benefits, particularly in patients with comorbidities such as Type 2 diabetes [12]. The shift from traditional procedures like gastric banding—once the first-line treatment—reflects a broader trend toward choosing surgical options with proven long-term success and improved patient outcomes [13]. Overall, the increasing adoption of LSG and RYGB underscores a growing recognition of these procedures’ effectiveness in achieving sustainable weight loss and resolving obesity-related health issues. It has been linked to many benefits including increased fertility, menstrual cycle regularity [14], and reducing the risk of GDM and PIH [15]. Although having many benefits, MBS is accompanied by some risks, like increasing rates of intrauterine growth restriction (IUGR) and small-for-gestational-age (SGA) infants [15]. It also increases the risk of vitamin deficiencies and pregnancy complications due to rapid weight loss [14], and even late complications of this surgery during pregnancy have been reported [16]. The aim of this narrative review is to present a comprehensive overview of the benefits and risks of MBS on pregnancy outcomes, like the risk of malnutrition and vitamin deficiency, maternal anemia, the development of internal hernia, reduced risk of pregnancy-induced hypertension, gestational diabetes, and higher risk of SGA outcomes. Overview of metabolic and bariatric surgery procedures Based on the mechanism through which weight loss is elicited, bariatric surgeries can be classified into Restrictive, Malabsorptive, and Combined Restrictive–Malabsorptive procedures (Fig. 1). Anatomical changes in common MBS procedures (made by BioRender) Restrictive These surgeries limit the stomach’s capacity for food, which helps reduce calorie intake without affecting nutrient absorption. These techniques include sleeve gastrectomy (SG) and Adjustable Gastric Banding (AGB). In SG, which accounts for most of the bariatric surgeries done globally, approximately 80% of the stomach is removed, whereas in AGB, a silicone band is placed around the upper part of the stomach, creating a small pouch. The band is adjustable through a port and restricts food intake without affecting digestion [8]. Advantages of these methods comprise low risk of nutrient malabsorption and less complication risks, but disadvantages include gastroesophageal reflux and weight regain in some patients due to stomach dilation over time [8, 17]. Malabsorptive These surgeries limit the absorption of nutrients by bypassing a portion of the small intestine. They are less commonly performed today due to nutritional complications. Biliopancreatic Diversion with Duodenal Switch (BPD-DS) is an example of this surgical technique. In this surgery, a significant portion of the stomach is removed, and a large section of the small intestine is bypassed, limiting the absorption of calories and nutrients. It has the highest level of weight loss and is the best option for treating comorbidities like type 2 diabetes, but it has a high risk of nutritional deficiencies, requires lifelong follow-up and supplementation, and has more operational risks due to greater technical complexity. This surgery is performed infrequently due to complexity and risks and accounts for less than 1% of bariatric surgeries in the US [17]. Combined restrictive–malabsorptive These surgeries use both restriction, limiting the amount of food intake, and malabsorption, limiting nutrient absorption, to achieve weight loss. Roux-en-Y Gastric Bypass (RYGB) is placed in this group. Historically being the most performed MBS, it is now second to sleeve gastrectomy in terms of popularity due to higher complexity. In this surgery, a small gastric pouch is created and connected directly to the jejunum, bypassing the rest of the stomach and part of the small intestine. This limits both food intake and nutrient absorption. This technique causes significant weight loss, has a high treatment rate for type 2 diabetes, and is a well-established procedure with long-term data supporting its effectiveness. Though being greatly beneficial, it causes problems like nutrient deficiencies needing lifelong follow-up and nutritional supplementation and has a risk of serious complications such as internal hernias, ulcers, and bowel obstruction due to the complexity of the procedure (Table 1) [8, 17]. Table 1Comparison of different MBS techniques [8, 18, 19]Surgery typeProcedureMechanismExcess weight lossComorbidity improvement (T2DM)Complication risksRestrictiveSleeve Gastrectomy (SG)Stomach size reduction51–70%Moderate to highGERD, leaks, weight regain over timeAdjustable Gastric Banding (AGB)Stomach restriction via a band ~ 34%ModerateHigh reoperation, band slippage, erosionMalabsorptiveBPD-DSStomach and small bowel bypass ~ 70%HighestNutrient deficiencies, diarrheaCombinedRoux-en-Y Gastric Bypass (RYGB)Small pouch + small bowel bypass ~ 70%HighDumping syndrome, internal hernias, ulcersBPD-DS (Also combined technique)Restriction + significant malabsorption ~ 70%HighestProtein malnutrition, vitamin deficiencies Comparison of different MBS techniques [8, 18, 19] Methods The methodology of the presented literature review was based on PubMed searches. The search was carried out in October 2024 using the following MeSH terms: “bariatric surgery” AND “pregnancy outcome,” “bariatric surgery” AND “obesity, maternal,” “bariatric surgery” AND “infant, newborn,” “bariatric surgery” AND “diabetes, gestational,” “bariatric surgery” AND “pre-eclampsia,” “bariatric surgery” AND “pregnancy complications,” “bariatric surgery” AND “pregnancy nutrition,” and “bariatric surgery” AND “prenatal nutritional physiological phenomena,” “bariatric surgery” AND “fertility” AND “pregnancy outcome.” Studies were excluded if they were published before 2014, did not specifically address pregnancy outcomes in women with obesity and after MBS, or were textbooks, letters, editorials, conference abstracts, or commentaries. We included systematic reviews, meta-analyses, and clinical trials published between 2014 and 2024. All included studies were in English, involved human subjects, and had full text availability. Manual searches of bibliographic lists were conducted for all included articles. The review focused particularly on studies examining the impact of bariatric surgeries on maternal and child well-being during pregnancy and postpartum periods. In addition to the inclusion/exclusion criteria, all selected studies underwent quality assessment using the Newcastle–Ottawa Scale (NOS) for observational studies and the Cochrane Risk of Bias Tool for randomized trials. Studies were evaluated based on selection bias, comparability, and outcome assessment. Only studies meeting a predetermined quality threshold (e.g., NOS score ≥ 7 for cohort studies) were included to ensure robustness. This process was conducted independently by two authors, with discrepancies resolved through discussion. Pregnancy outcomes in women with obesity Nearly 25% of pregnant women in the United States have obesity, and the prevalence is particularly notable among underrepresented racial and ethnic groups [20]. Maternal obesity significantly impacts both maternal and fetal health outcomes throughout pregnancy, delivery, and postpartum periods. Obesity in pregnancy is linked to a significantly higher risk of maternal and fetal complications, including gestational diabetes mellitus (GDM), showing a 15% increase in this population [21], hypertensive disorders of pregnancy, including gestational hypertension and preeclampsia[22], and higher rates of cesarean deliveries, with associated risks of surgical and postoperative morbidities, among the maternal complications of the rise in obesity during pregnancies [23]. From a fetal perspective, maternal obesity significantly increases risks during pregnancy and delivery. Studies demonstrate higher rates of fetal macrosomia and large-for-gestational-age (LGA) infants in mothers with obesity [23]. Congenital anomalies, as well as perinatal mortality, are also seen more often in these pregnancies [22, 23]. From a fertility perspective, reproductive potential is also affected by obesity through various mechanisms including hyperleptinemia, hyperinsulinemia, and hyperandrogenism. Women with obesity often experience menstrual abnormalities and decreased fertility rates compared to women with normal BMI [24]. Moreover, the presence of obesity before conception is seen to influence the success rates of assisted reproductive technologies, linking a higher BMI with poorer reproductive outcomes [25]. The impact of obesity extends to delivery outcomes as well. Studies report higher rates of labor induction, prolonged labor, and emergency cesarean sections in pregnant women with obesity [26]. Furthermore, the risk of postpartum complications, including hemorrhage, wound infections, and thromboembolism, is also elevated in this population [26, 27]. As these women approach the postpartum period, both the mother and child may face long-term complications. While mothers with obesity are more likely to retain significant weight postpartum, children born to these mothers face increased risks of childhood obesity and associated metabolic disorders [28, 29]. The management of obesity during pregnancy presents significant challenges. Traditional interventions, including dietary modifications and lifestyle changes, often show limited success in achieving meaningful weight reduction [20, 24]. This has led to increased consideration of MBS as an intervention for women of reproductive age with severe obesity, particularly when conventional methods prove ineffective. Pregnancy outcomes in women after MBS Roux-en-Y gastric bypass (RYGB) Metabolic and nutritional changes Women who undergo RYGB experience significant alterations in glucose metabolism during pregnancy. Studies demonstrate increased glycemic variability compared to other bariatric procedures, with particular concerns regarding postprandial hypoglycemia [30]. Research indicates that 49.6% of post-RYGB pregnant patients experience hypoglycemic episodes during oral glucose tolerance testing, complicating the diagnosis and management of gestational diabetes [31]. These glucose abnormalities are associated with adverse pregnancy outcomes and require careful monitoring throughout gestation [32]. Another major concern in post-RYGB pregnancies is nutritional deficiencies. Studies report a high prevalence of vitamin A deficiency throughout pregnancy, with 57% of women experiencing night blindness in each trimester [33]. Moreover, iron deficiency and anemia are particularly problematic, especially in pregnancies occurring more than 18 months after surgery, with studies showing significantly higher rates of anemia (up to 40.8%) during these pregnancies [34]. Surgical complications Pregnancy after RYGB presents unique surgical risks that require vigilant monitoring and a high index of suspicion. Upper abdominal pain– the most common presenting symptom– is reported in 37.2% of pregnant women post-RYGB, with 9.7% ultimately diagnosed with internal herniation [35]. The diagnostic challenge lies in differentiating normal pregnancy discomfort from potentially life-threatening complications. Studies demonstrate that surgery was required in 46.9% of cases presenting with abdominal pain, with internal herniation being the most frequent finding during exploratory laparotomy [36]. The altered gastrointestinal anatomy predisposes to several other complications: bowel obstruction occurs in 3–5% of pregnancies, typically due to adhesions or internal herniation at the mesenteric defects [27, 36]. Marginal ulcers develop in approximately 2% of cases, likely exacerbated by pregnancy-induced hormonal changes and increased gastric acid production [27, 36]. These ulcers may present with epigastric pain, nausea, or gastrointestinal bleeding, often requiring proton pump inhibitor therapy. The risk of internal herniation persists throughout all trimesters but may be particularly concerning during the second and third trimesters when uterine expansion significantly increases intra-abdominal pressure [35, 36]. This mechanical stress, combined with hormonal ligamentous laxity, may further predispose to hernia formation at mesenteric defects. Delayed diagnosis can lead to catastrophic outcomes including bowel ischemia, perforation, and fetal compromise, underscoring the need for low-threshold imaging in symptomatic patients. Given these risks, multidisciplinary management involving bariatric surgeons, obstetricians, and radiologists is crucial for optimal outcomes. A high index of suspicion should be maintained even for nonspecific symptoms, as atypical presentations are common in this population. The diagnostic challenge is twofold: (1) pregnancy-related anatomical changes (e.g., uterine displacement of organs) may obscure classic signs of internal hernia and (2) reluctance to use ionizing radiation (CT) delays diagnosis. However, MRI (non-ionizing) has 85–90% sensitivity for internal herniation and should be prioritized when clinical suspicion arises [36]. Key red flags that can raise suspicion include pain disproportionate to physical exam findings, recurrent vomiting with postprandial worsening, and metabolic acidosis without other etiology [35, 36]. Maternal outcomes RYGB demonstrates significant benefits in reducing obesity-related pregnancy complications. Multiple studies consistently show lower rates of GDM compared to non-operated controls with obesity [26]. Significant reductions of hypertensive disorders of pregnancy, including preeclampsia, have also been reported [23]. Nevertheless, weight management during pregnancy requires careful monitoring. Studies indicate that post-RYGB women often struggle with appropriate gestational weight gain, with both insufficient and excessive gains observed [37]. Among women with RYGB, 55% fell below the Institute of Medicine (IOM) guidelines for gestational weight gain (defined as < 5 kg for obese BMI class II/III) [37, 38]. This inadequate weight gain was most pronounced in pregnancies occurring < 18 months post-surgery (67% vs 42% in later pregnancies) and correlated with higher rates of preterm delivery (18% vs 9%) and SGA infants (23% vs 14%) [37, 38]. However, interpretation requires caution as the IOM guidelines were developed for non-surgical obese pregnancies, and women with significant residual excess weight may have different metabolic requirements [37, 38]. After RYGB, cardiovascular adaptation and hemodynamic profiles appear to improve compared to non-operated women with obesity [39]; however, due to the increased risk of nutritional deficiencies and potential surgical complications, ongoing monitoring is crucial to ensure favorable outcomes. Fetal/neonatal outcomes Post-RYGB pregnancies show distinct patterns in fetal growth and development. A significant finding is the increased risk of small-for-gestational-age (SGA) infants, with studies reporting rates up to 20% higher than in non-operated controls [40]. Detailed ultrasound studies have revealed specific patterns of fetal growth restriction, with lower fetal subcutaneous adipose tissue thickness observed during pregnancy. This growth pattern appears to be independent of maternal glucose metabolism or weight loss, suggesting other mechanisms may be involved [41]. Furthermore, birth weight seems to be consistently lower in RYGB offspring, with studies showing an average reduction of 340 g compared to control groups [40]. Despite these differences, most studies report no significant increase in adverse neonatal outcomes when appropriate monitoring and care are provided [42]. Sleeve gastrectomy (SG) Sleeve gastrectomy has gained increasing popularity as a bariatric procedure, with studies showing its growing prevalence among women of reproductive age [43]. The procedure’s primary advantage lies in its relatively simpler technique and preservation of normal gastrointestinal anatomy, which potentially offers different risk profiles for pregnancy compared to malabsorptive procedures [44]. Metabolic and nutritional changes The metabolic profile during pregnancy following sleeve gastrectomy shows distinct characteristics compared to other bariatric procedures. Studies comparing SG with RYGB demonstrate important differences in glucose metabolism during pregnancy, with SG patients exhibiting more stable glycemic profiles and significantly lower risk of hypoglycemic events [30, 37, 45]. This improved glycemic stability is attributed to the preserved pyloric function and duodenal absorption, leading to better glucose homeostasis throughout pregnancy [32]. While nutritional deficiencies are still a concern, their pattern and severity differ from those observed in malabsorptive procedures. Research indicates that pregnant women after SG require careful nutritional monitoring, particularly for micronutrients including iron, vitamin B12, and folate levels [46]. The restrictive nature of the procedure can lead to reduced dietary intake, potentially affecting maternal nutritional status during pregnancy, though studies suggest these deficiencies are generally less severe than those observed in RYGB [47, 48]. Surgical complications The risk profile for surgical complications during pregnancy differs significantly in SG compared to other bariatric procedures, particularly RYGB. The absence of potential internal herniation sites results in lower rates of acute surgical emergencies during pregnancy [27, 36]. However, specific complications deserve attention. Gastric reflux, often exacerbated by increased intra-abdominal pressure during pregnancy, appears more prevalent in SG patients compared to other procedures [46]. Maternal outcomes As with other bariatric procedures, SG demonstrates significant effectiveness in reducing obesity-related pregnancy complications. Studies have documented substantial reductions in gestational diabetes compared to non-operated controls with obesity[23, 44]. Gestational weight gain patterns following SG show distinct characteristics that differentiate it from other bariatric procedures. Studies indicate higher rates of appropriate gestational weight gain (defined as a 5–9 kg total gain for patients with preoperative BMI ≥ 35 kg/m2, adapted from IOM guidelines[43]) compared to RYGB, attributed to better food tolerance and preserved gastrointestinal continuity [49]. The impact on long-term weight management is particularly noteworthy, as research demonstrates that pregnancy does not significantly compromise the weight loss benefits of SG [50]. The timing of pregnancy after SG has been extensively studied, with particular attention to early pregnancy outcomes. Research focusing on pregnancies within the first 12 months post-surgery shows no significant increase in adverse outcomes compared to later pregnancies [51]. This finding contrasts with traditional recommendations to delay pregnancy after MBS and suggests potentially more flexibility in conception timing after SG compared to other bariatric procedures [52]. Fetal/neonatal outcomes Fetal growth patterns following SG demonstrate unique characteristics that distinguish it from other bariatric procedures. Multiple comprehensive studies show that while SG effectively reduces the incidence of large-for-gestational-age infants compared to non-operated controls with obesity, it maintains a lower rate of small-for-gestational-age infants compared to RYGB [26, 53]. This balanced effect on fetal growth is particularly significant, as it suggests that SG might achieve an optimal middle ground between the benefits of maternal weight reduction and the risks of excessive fetal growth restriction [44, 54]. Moreover, birth weight distributions in SG pregnancies show a more favorable pattern compared to other bariatric procedures. SG shows lower rates of SGA infants than RYGB (12% vs 23%, p < 0.01) and comparable rates to AGB (12% vs 10%, p = 0.34) [53, 55]. Studies analyzing large cohorts report mean birth weights closer to those of normal-weight controls, with less deviation toward either extreme [55, 56]. This finding is particularly relevant as it suggests that SG might better preserve the physiological mechanisms regulating fetal growth [57]. Immediate neonatal outcomes show several advantages in SG pregnancies. Research demonstrates lower rates of NICU admission compared to RYGB pregnancies [58]. Also, Apgar scores tend to be more favorable, suggesting better immediate postnatal adaptation [42]. The long-term developmental trajectory of children born to mothers after SG has been the subject of several follow-up studies. Potentially better metabolic outcomes have been reported compared to offspring of mothers with other bariatric procedures [28, 56]. These improved outcomes may be attributed to several factors, including better maternal nutritional status during pregnancy, more stable glucose metabolism, and reduced risk of extreme birth weights [29]. Furthermore, neurodevelopmental outcomes also appear favorable, though long-term data remain limited. Studies following children up to school age suggest normal cognitive development and behavioral patterns, with some evidence indicating potentially better outcomes compared to children of non-operated mothers with obesity [59]. Given that only 19% of women of reproductive age who undergo bariatric procedures receive proper preconception counseling during their operation [43], procedure selection typically prioritizes immediate weight loss needs and comorbidity resolution rather than future pregnancy considerations [17, 43]. Adjustable gastric banding (AGB) While AGB utilization has declined to < 5% of contemporary bariatric procedures due to high complication rates and inferior weight loss [17, 43], pregnancy-specific risks remain clinically relevant for legacy patients. AGB represents a purely restrictive bariatric procedure that offers unique advantages and considerations for pregnancy. The ability to adjust the band during pregnancy provides a level of control not available with other bariatric procedures, though this feature also introduces specific management challenges [60]. Management considerations The adjustable nature of the band requires specific attention during pregnancy. Studies indicate that band adjustment may be necessary throughout gestation to accommodate the physiological changes of pregnancy and ensure adequate nutritional intake [43]. Band adjustments are typically required during the first and second trimesters, with many centers advocating for partial deflation to prevent excessive restriction and ensure adequate nutritional intake [26]. Nutritional status Compared to malabsorptive procedures, AGB presents a different profile of nutritional concerns. While severe micronutrient deficiencies are less common due to preserved intestinal absorption, the restrictive component can lead to reduced overall nutrient intake [46, 47]. Studies show that proper band adjustment is crucial in maintaining adequate nutritional status, with careful monitoring needed to balance restriction and sufficient dietary intake [61, 62]. Maternal outcomes The impact of AGB on maternal outcomes shows some distinct patterns. Research demonstrates significant reductions in gestational diabetes and hypertensive disorders, though these improvements may be less pronounced than with other bariatric procedures [23]. With AGB, higher rates of appropriate weight gain are seen compared to other bariatric procedures, which is likely due to the ability to adjust restriction [63, 64]. However, this advantage comes with the need for careful monitoring and regular band adjustments to maintain optimal restriction throughout pregnancy. Notably, the risk of band-specific complications during pregnancy requires attention. Studies report cases of band slippage, erosion, and port-related issues during pregnancy, though these complications appear relatively rare with proper monitoring [27, 36]. Fetal/neonatal outcomes AGB demonstrates distinct patterns in fetal growth and development compared to other bariatric procedures. Studies show that infants born to mothers with AGB have birth weights that more closely approximate those of the general population, with lower rates of both SGA and LGA infants compared to other bariatric procedures [65]. This balanced outcome is attributed to the preserved gastrointestinal anatomy and the ability to adjust restriction during pregnancy [44, 60]. Moreover, growth patterns during pregnancy show more favorable trajectories in AGB pregnancies, with ultrasound studies demonstrating more consistent fetal growth patterns as well as lower rates of growth restriction compared to malabsorptive procedures [53, 54]. Management considerations Pregnancy significantly exacerbates AGB-specific complications due to physiological changes. The most concerning risks include band slippage or erosion, occurring in 8.7% of pregnancies (three times baseline risk), primarily attributed to hormonal ligamentous laxity and gastric displacement [27, 36]. Port-related complications such as infection or displacement develop in 12% of cases, often requiring imaging avoidance [27]. Additionally, AGB demonstrates inferior weight loss outcomes (34% excess weight loss versus 51–70% with SG/RYGB) and high long-term reoperation rates (25–40%), with many interventions occurring during pregnancy [17, 36]. These limitations, combined with the frequent need for band adjustment or removal during gestation, have contributed to AGB’s decline to less than 5% of contemporary bariatric procedures, particularly for reproductive-aged women [17, 43]. Long-term follow-up studies of children born to mothers with AGB show interesting patterns. Research indicates that these children may have more favorable metabolic profiles compared to those born to mothers with other bariatric procedures or non-operated mothers with obesity [28, 56]. Also, growth trajectories during childhood appear more consistent, with lower rates of childhood obesity reported [29]. The cognitive and developmental outcomes of children born to mothers with AGB have also been studied. Research suggests normal neurodevelopmental patterns, with some studies indicating potentially better outcomes compared to children of non-operated mothers with obesity [59]. However, long-term follow-up data remain limited, and more research is needed to fully understand the developmental implications. Biliopancreatic diversion with duodenal switch (BPD-DS) Biliopancreatic diversion represents the most extensive malabsorptive bariatric procedure, carrying unique implications for pregnancy outcomes. The significant anatomical alterations and malabsorptive effects create distinct challenges that require careful consideration in the context of pregnancy [66]. Metabolic and nutritional considerations BPD-DS presents the most significant nutritional challenges among bariatric procedures during pregnancy. Studies demonstrate severe nutritional deficiencies, particularly in fat-soluble vitamins, proteins, and micronutrients [47, 67]. The malabsorptive component is particularly problematic during pregnancy, with studies showing significantly higher rates of anemia, protein deficiency, and calcium metabolism disorders compared to other bariatric procedures [46]. BPD-DS induces severe nutritional deficiencies (60–80% prevalence) despite supplementation, with vitamin A (57%), D (72%), and protein (40%) being most affected due to malabsorption [46, 67]. Standard prenatal vitamins are inadequate; requirements include 2–3 × doses for fat-soluble vitamins and parenteral therapy in 35% of cases [61, 67]. Monthly monitoring of albumin, PT/INR, and micronutrients is essential, as deficiencies correlate with 3.2-fold higher SGA risk [40] and increased NICU admissions [55]. These risks justify guidelines discouraging BPD-DS in reproductive-aged women [43, 48]. As summarized in Table 2, BPD-DS requires particularly intensive nutritional surveillance, with monthly monitoring of fat-soluble vitamins and protein status. Table 2Nutritional monitoring in bariatric surgeries based on procedureProcedureCritical nutrients to monitorMonitoring frequencyHigh-risk deficiencies (incidence)ReferencesBPD-DSVitamins A, D, E, K; Iron; Zinc; ProteinMonthly during pregnancyVitamin A (57%), Protein (40%)[46, 67]RYGBIron, Vitamin B12, Calcium, Vitamin DQuarterlyIron (40.8%), B12 (32%)[34, 47]SGIron, Vitamin B12, FolateAnnually (Quarterly if deficient)Iron (25%), B12 (18%)[48, 49]AGBIron (if dietary intake inadequate)As clinically indicatedRare (≤ 10%)[60] Nutritional monitoring in bariatric surgeries based on procedure BPD-DS demands lifelong nutritional surveillance and supplementation, with particular urgency for women of reproductive age. Given that this procedure is typically reserved for patients with severe obesity (BMI ≥ 50 kg/m2) or metabolic comorbidities refractory to other interventions [17, 43], pre-pregnancy counseling is critical. Prior to conception, patients require 3–6 months of high-dose fat-soluble vitamin repletion (A, D, E, K) and protein optimization to mitigate deficiency risks, as deficiencies persist in 60–80% of cases despite supplementation [46, 48, 67]. For those desiring pregnancy, conversion to RYGB or SG may be considered, as limited data suggest a 40% reduction in small-for-gestational-age risk post-conversion [66]. However, BPD-DS should generally be avoided in women planning future pregnancy due to its irreversible malabsorptive effects and high complication rates [43, 48]. Maternal complications While BPD-DS effectively reduces obesity-related pregnancy complications, it introduces specific risks that require careful monitoring. Studies show higher rates of maternal complications compared to other bariatric procedures, particularly related to nutritional deficiencies and malabsorption [46]. The risk of surgical complications during pregnancy is also higher with BPD-DS compared to other procedures. This includes increased rates of internal hernias (12% vs 5% in RYGB), bowel obstruction, and other surgical emergencies requiring intervention during pregnancy [27, 36]. Another unique challenge regarding BPD-DS is weight management during pregnancy. Higher rates of inadequate gestational weight gain have been reported, with some women experiencing continued weight loss during pregnancy despite dietary modifications [63, 68]. This pattern raises particular concerns about fetal nutrition and growth [64]. Furthermore, birth outcomes in BPD-DS pregnancies show several concerning trends. Multiple studies report significantly higher rates of preterm birth compared to other bariatric procedures [69]. Birth weights are consistently lower, with research documenting mean reductions of 400–600 g compared to other procedures [40]. The frequency of NICU admission and neonatal complications is also elevated in BPD-DS pregnancies compared to other bariatric procedures [42, 55]. Additionally, studies have noted more frequent neurodevelopmental concerns in these children compared to those born after other bariatric procedures [59]. These outcomes have led many centers to recommend against BPD-DS as a primary bariatric procedure for women of reproductive age, or to strongly advise completing childbearing before undergoing this procedure [43, 48]. Comparative analysis of different procedures Direct comparison of outcomes between different bariatric procedures provides valuable insights for surgical planning in women of reproductive age. Multiple large-scale studies have evaluated the relative benefits and risks of each procedure type in the context of subsequent pregnancies [44, 60]. Metabolic and nutritional comparsons The nutritional impact varies significantly between procedures, with a clear gradient of risk from purely restrictive to predominantly malabsorptive operations. AGB and SG demonstrate lower rates of nutritional deficiencies compared to RYGB and BPD-DS [46, 47]. Iron deficiency anemia, particularly problematic during pregnancy, shows increasing prevalence from AGB (lowest) to BPD-DS (highest), with intermediate rates in SG and RYGB [34]. Glucose metabolism also shows procedure-specific patterns; RYGB and BPD-DS demonstrate the most dramatic improvements in glucose homeostasis but also carry the highest risk of reactive hypoglycemia [30, 32, 37]. Surgical complications The risk of acute surgical complications during pregnancy varies significantly by procedure type. Internal herniation risk is highest with RYGB, minimal with SG, and absent with AGB [27, 35]. However, AGB presents unique risks related to band adjustment and potential slippage during pregnancy, requiring specific monitoring protocols [36]. Maternal outcomes comparison Cross-procedural analysis reveals varying effectiveness in reducing obesity-related pregnancy complications. All procedures demonstrate significant reductions in gestational diabetes and hypertensive disorders compared to non-operated controls with obesity, but the magnitude of this effect differs [23, 70]. RYGB and BPD-DS show the most dramatic reductions in gestational diabetes (60–75% reduction), while SG and AGB demonstrate moderate improvements (40–55% reduction) [21, 45]. Furthermore, gestational weight gain patterns show procedure-specific variations. While AGB offers the unique advantage of adjustability, allowing more precise control of weight gain during pregnancy[63, 68], RYGB and BPD-DS are associated with higher rates of inadequate weight gain, and SG demonstrates intermediate patterns [64]. Fetal/neonatal outcomes comparison Birth weight distributions show clear procedure-related patterns. RYGB and BPD-DS are associated with the highest rates of SGA infants (20–35%), while SG and AGB show more moderate rates (10–15%) [53]. Fetal growth patterns demonstrate procedure-specific characteristics, with ultrasound studies revealing earlier and more pronounced growth restrictions in malabsorptive procedures compared to restrictive ones [41, 54]. Moreover, long-term offspring outcomes vary significantly between procedures. Children born after restrictive procedures (AGB and SG) show more favorable metabolic profiles compared to those born after malabsorptive procedures [28, 56]. Neurodevelopmental outcomes also appear to favor restrictive procedures, though long-term data remain limited [29, 59]. This comparative analysis suggests that while all bariatric procedures improve pregnancy outcomes compared to untreated obesity, the choice of procedure for women of reproductive age should carefully consider the balance between metabolic benefits and potential risks to maternal and fetal health [43]. Surgery to conception interval The optimal timing of pregnancy after MBS remains a subject of significant research and debate. While traditional recommendations advised delaying pregnancy for 12–24 months after surgery, recent evidence suggests that this guidance may need to be more nuanced and procedure-specific [71]. The historical recommendation for delayed conception was based on several theoretical concerns. These included the period of rapid weight loss potentially affecting fetal nutrition, the risk of nutritional deficiencies being highest in the early postoperative period, and the need for weight stabilization before pregnancy [52, 72].Recent research has challenged these traditional guidelines, suggesting that pregnancy outcomes may not be significantly compromised by earlier conception. Multiple studies have demonstrated comparable maternal and fetal outcomes in pregnancies occurring before and after the traditionally recommended waiting period [71, 73]. Procedure-specific timing considerations The optimal surgery-to-conception interval appears to vary by surgical procedure. For SG, studies indicate that pregnancies occurring within the first year post-surgery show comparable outcomes to later pregnancies [49, 51]. In contrast, RYGB pregnancies show more complex timing-related outcomes. While early pregnancies are not universally associated with adverse outcomes, studies indicate that the risk of nutritional deficiencies, particularly iron deficiency anemia, actually increases with longer intervals from surgery [34, 38]. For AGB, the timing appears less critical due to the ability to modify restriction during pregnancy, though adequate time for band stabilization is recommended [58]. Finally, BPD-DS shows the most stringent timing requirements, with studies suggesting better outcomes with longer intervals to allow for nutritional stabilization [66]. Weight loss trajectory and conception The relationship between weight loss trajectory and pregnancy timing has emerged as a more relevant factor than strict time intervals. Studies suggest that conception during periods of rapid weight loss may be more problematic than early conception in women who have achieved weight stability [68]. Research demonstrates that women who conceive after reaching a stable weight, regardless of the post-surgical interval, show better outcomes in terms of gestational weight gain and fetal growth [64]. Nutritional status and timing The relationship between surgery–conception interval and nutritional status shows complex patterns. Contrary to traditional assumptions, longer intervals do not necessarily correlate with better nutritional status. Studies indicate that the risk of certain deficiencies, particularly iron and vitamin B12, may actually increase with time from surgery [67]. Metabolic considerations and timing The metabolic adaptation following MBS significantly influences the optimal timing of conception. Research indicates that glucose metabolism and insulin sensitivity continue to improve for several months post-surgery, suggesting that allowing time for metabolic stabilization may be beneficial [37]. Psychological and behavioral aspects The timing of conception also relates to psychological readiness and behavioral adaptation. Studies indicate that women who achieve stable dietary patterns and consistent supplement adherence before conception, regardless of the exact post-surgical interval, demonstrate better pregnancy outcomes [43, 61]. Impact on long-term outcomes The surgery-to-conception interval appears to influence long-term outcomes for both mother and child. Research examining extended follow-up periods shows that early conception may affect sustained weight loss outcomes in mothers; however, these effects vary by procedure type and individual factors such as pre-pregnancy BMI and weight loss trajectory [50]. Also, children born at different post-surgical intervals show varying patterns in their long-term development, including differences in growth patterns, metabolic profiles, and developmental outcomes [28, 56]. Clinical implications and recommendations Current evidence suggests that rigid time-based recommendations should be replaced with individualized approaches based on multiple factors [72]. Key considerations should include the specific bariatric procedure performed, individual weight loss patterns and metabolic stability, nutritional status and supplement adherence, and overall health status including psychological readiness [43]. Limitations The current study has some inherent limitations, mainly due to the use of a narrative approach. Although this approach allows for an in-depth examination of topics, it lacks the rigorous structure that is a feature of systematic reviews or meta-analyses. Without a well-defined framework for selecting and interpreting the studies included, narrative reviews are prone to several biases by nature. The studies included herein varied greatly in methods, sample sizes, and follow-up periods. Many of the studies had relatively small sample sizes, particularly with respect to certain bariatric procedures or rare complications. Another major difficulty in direct comparison was the lack of standardized control over patients’ pre-existing medical histories and comorbidities, as well as the variations in surgical techniques even within similar procedural categories. Most studies of pregnancies following MBS are limited by few data points on long-term follow-up with regard to developmental outcomes in children. This pattern reflects a more general paucity of appropriate longitudinal studies of outcomes in children years after birth. Moreover, the timing of pregnancies in relation to MBS proved to be a critical factor in many studies; therefore, making it very hard to reach a clear-cut conclusion as to the optimal interval between surgical intervention and conception. Additionally, there was great variation among the studies and hospitals regarding the indication for nutritional monitoring and supplementation, which might have blurred the assessment of nutritional risks directly related to the surgical procedures. Overall, systematic reviews and meta-analyses of such studies with regard to specific outcomes and procedures are therefore necessary to establish more definitive evidence-based guidelines for managing pregnancies after MBS, and future research should focus on larger cohort studies with standardized protocols and extended follow-up. Conclusion MBS significantly affects pregnancy outcomes, showing beneficial effects and potential risks at the same time, depending on the type of surgical procedure. Evidence suggests that lower rates of obesity-related complications in pregnancy consistently occur in all types of bariatric procedures performed for gestational diabetes and hypertensive disorders. Weighed against these benefits are procedure-specific risks, particularly in nutritional deficiencies and fetal growth patterns. While bariatric surgery universally improves pregnancy outcomes compared to untreated obesity, procedure selection must account for both reproductive risks and life-threatening comorbidities. For women with severe obesity (BMI ≥ 50 kg/m2) or end-organ damage (e.g., heart failure, cirrhosis), the survival benefits of BPD-DS or RYGB may outweigh pregnancy-specific risks [17, 43]. In these cases, shared decision-making should prioritize the following: (1) acute mortality reduction, (2) potential for future procedure conversion if pregnancy is desired [66], and (3) rigorous preconception optimization when malabsorptive procedures are unavoidable [46, 48]. This approach balances immediate health preservation with long-term reproductive planning. Malabsorptive procedures, while demonstrating the most spectacular improvements in obesity-related comorbidities, are also associated with the highest risk of both nutritional deficiencies and inadequate fetal growth outcomes. On the other hand, restrictive operations generally show an intermediate effect in terms of benefits and risks, thus potentially making them a more balanced alternative for women of reproductive age. Among women of reproductive age, sleeve gastrectomy (SG) is now the most common procedure (50% + of cases) due to its favorable safety profile and lower nutritional risks, while RYGB is reserved for severe metabolic disease. AGB and BPD-DS are rarely selected in this demographic due to band-related complications or severe malabsorption, respectively [10, 17, 43]. The timing of conception after MBS is an important consideration; however, to recommend a standardized two-year wait for pregnancy would almost certainly be an oversimplification of the issue. Ideal time for pregnancy depends on the type of surgery and on individual circumstances that might eventually prove to be more relevant than strict intervals of time alone. Additionally, while weight stabilization is valuable, the absence of a clear consensus hinders its practical use, and procedure-specific time intervals (12–24 months) remain more practical benchmarks which can typically encompass the period of active weight loss and metabolic adaptation for most patients. The evidence reviewed in this study strongly supports the need for an individualized, procedure-specific approach to the management of pregnancy after MBS. Such success depends on coordinated care among several specialties besides standardized protocols for surveillance and support systems for mothers and children. More research over the coming decades will be needed to provide more precise guidelines and long-term health implications for offspring from each procedure. Author contributions All authors contributed to the study conception and design. Material preparation, data collection and review were performed by PK, MR, AH and SMA. The first draft of the manuscript was written by MM and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript. Funding The authors declare that no funds, grants, or other support was received during the preparation of this manuscript. Data availability No datasets were generated or analysed during the current study. Declarations Conflict of interest The authors declare no competing interests. Ethics approval This is a literature review study. The Shiraz University of Medical Sciences Research Ethics Committee has confirmed that no ethical approval is required. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.